QA: Viracta Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2021_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 22,144,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,103,000
4 LiabilitiesCurrent 3,310,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,164,667
9 ResearchAndDevelopmentExpense 11,182,218
10 remainder_Expenses 265,803
11 remainder_Revenues 513,924
12 remainder_NetIncome 811,496
13 remainder_ComprehensiveNetIncome -536
  yvar yval
0 Assets 23,247,000
1 Liabilities 3,310,000
2 Expenses 21,612,688
3 Revenues 513,924
4 StockholdersEquity 19,937,000
5 NetIncome -20,287,268
6 ComprehensiveNetIncome -20,287,536
7 BaseVar 24,747,822
8 EconomicCapitalRatiobeforeLimitedLiability 1.75
9 EconomicCapitalRatio 2.85

Edgar->Model Mapping

Feature Distribution

Change over Time